Look at big picture:
1. the insiders who sold $18 mil as AFR, however existing insiders still own 0.93% of A2m, it is $97mil of $10,466mil. that says 81% insiders is not sold, majority to 19% who sold. Why a big deal?
2. It is rationale to key management to sold half of their share, to the doctrine of diversification: their remuneration income and shares options is 100% tired to A2m. however, they can not pull out their future salary earning to diversify the family wealth which comes as a A2m windfall. It is rationale to cash out share or options to move outside A2m for Pease of mind.
3. I do not mean disrespect to key management. Shareholding/ investment are more a phycology game. 90% of human being fails on share market. there is no exception to key management who may only excellent on a narrow skill field, like running A2m.4. follow the leader, that means follows who make big money in buy and sell shares for a living, not means follow the managements,
5. why management is not good at estimated its company share performance, key management look into vertical (their own company), investors compare horizontal (listed companies), insiders trend to know more drawbacks which they work hard to improve, however, shareholders compare A2m with hundred listed companies for competiveness equally without single out a company’s drawbacks or undisclosed management issues.
In conclusion: Share investors have a better grip to pick shares for better performance in the market.
- Forums
- ASX - By Stock
- A2M
- AFR Rear window pose a stupid question
AFR Rear window pose a stupid question, page-5
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.52 |
Change
0.070(1.28%) |
Mkt cap ! $3.808B |
Open | High | Low | Value | Volume |
$5.50 | $5.62 | $5.45 | $4.291M | 775.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 11749 | $5.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.54 | 4376 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5399 | 5.630 |
6 | 17273 | 5.610 |
4 | 33072 | 5.600 |
4 | 20359 | 5.590 |
2 | 7656 | 5.580 |
Price($) | Vol. | No. |
---|---|---|
5.650 | 7091 | 2 |
5.670 | 9037 | 3 |
5.680 | 9833 | 4 |
5.690 | 6747 | 2 |
5.700 | 8222 | 4 |
Last trade - 10.39am 25/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online